Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: Insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trialHijazi, Z.; Siegbahn, A.; Andersson, U.; Granger, C.; Alexander, J.; Atar, D.; Gersh, B.; Mohan, P.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Wallentin, L.
2015Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudyHijazi, Z.; Siegbahn, A.; Andersson, U.; Lindahl, B.; Granger, C.; Alexander, J.; Atar, D.; Gersh, B.; Hanna, M.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Wallentin, L.
2010Apixaban for reduction in stroke and other ThromboemboLic events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationaleLopes, R.; Alexander, J.; Al-Khatib, S.; Ansell, J.; Diaz, R.; Easton, J.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Hylek, E.; McMurray, J.; Verheugt, F.; Wallentin, L.
2012Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialLopes, R.; Al-Khatib, S.; Wallentin, L.; Yang, H.; Ansell, J.; Bahit, M.; De Caterina, R.; Dorian, P.; Easton, J.; Erol, C.; Ezekowitz, J.; Gersh, B.; Granger, C.; Hohnloser, S.; Horowitz, J.; Hylek, E.; McMurray, J.; Mohan, P.; Vinereanu, D.; Alexander, J.
2014High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarinHijazi, Z.; Wallentin, L.; Siegbahn, A.; Andersson, U.; Alexander, J.; Atar, D.; Gersh, B.; Hanna, M.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Granger, C.
2013N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: Insights from the aristotle trial (apixaban for the prevention of stroke in subjects with atrial fibrillation)Hijazi, Z.; Wallentin, L.; Siegbahn, A.; Andersson, U.; Christersson, C.; Ezekowitz, J.; Gersh, B.; Hanna, M.; Hohnloser, S.; Horowitz, J.; Huber, K.; Hylek, E.; Lopes, R.; McMurray, J.; Granger, C.